These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17804773)

  • 21. Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
    Li CP; Chao Y; Chen LT; Lee RC; Lee WP; Yuan JN; Yen SH; Lee SD
    Scand J Gastroenterol; 2008 Aug; 43(8):992-9. PubMed ID: 19086281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical effect of ultraselective transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma originating from the caudate lobe: an analysis of 13 cases].
    Yuan HJ; Liu FY; Li X; Guan Y; Zuo TY; Wang MQ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):744-748. PubMed ID: 29108202
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
    Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH; Lee WJ; Lim HK; Lim JH
    J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [TACE: therapy of the HCC before liver transplantation--experiences].
    Herber S; Schneider J; Brecher B; Höhler T; Thelen M; Otto G; Pitton MB
    Rofo; 2005 May; 177(5):681-90. PubMed ID: 15871083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy.
    Okazaki M; Yamasaki S; Ono H; Higashihara H; Koganemaru F; Kimura S; Kuroda Y; Sato S; Ryu K; Ohtsubo T
    Hepatogastroenterology; 1993 Aug; 40(4):320-3. PubMed ID: 8406299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Sueyoshi E; Hayashida T; Sakamoto I; Uetani M
    AJR Am J Roentgenol; 2010 Jul; 195(1):245-51. PubMed ID: 20566824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images.
    Kim HC; Kim AY; Han JK; Chung JW; Lee JY; Park JH; Choi BI
    Radiology; 2002 Dec; 225(3):773-80. PubMed ID: 12461260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.
    Chung JW; Park JH; Han JK; Choi BI; Han MC
    AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome.
    Matsui O; Miyayama S; Sanada J; Kobayashi S; Khoda W; Minami T; Kozaka K; Gabata T
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):407-9. PubMed ID: 19885639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of MDCT angiography for determination of tumor-feeding vessels in chemoembolization of hepatocellular carcinoma.
    Kim I; Kim DJ; Kim KA; Yoon SW; Lee JT
    J Comput Assist Tomogr; 2014; 38(5):742-6. PubMed ID: 24834885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
    Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
    Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up].
    Haruno M; Shimamura R; Ogawa Y; Tanaka H; Sakai K; Araki K
    Gan To Kagaku Ryoho; 2005 May; 32(5):667-70. PubMed ID: 15918569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Nakashima Y; Ikeno H; Orito N; Notsumata K; Watanabe H; Toya D; Tanaka N; Matsui O
    Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1168-79. PubMed ID: 20058008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 350-560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacy.
    Zhao GS; Li C; Liu Y; Ren ZZ; Yuan XL; Zhou J; Zhang YW; Zhang M
    Medicine (Baltimore); 2017 Apr; 96(16):e6629. PubMed ID: 28422858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study.
    Caturelli E; Siena DA; Fusilli S; Villani MR; Schiavone G; Nardella M; Balzano S; Florio F
    Radiology; 2000 Apr; 215(1):123-8. PubMed ID: 10751477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.